Aarti Drugs Limited (NSE:AARTIDRUGS)
India · Delayed Price · Currency is INR 493.10
+3.65 (0.75%)
Aug 4, 2025, 3:30 PM IST
Aarti Drugs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Net Income | - | 1,682 | 1,714 | 1,663 | 2,050 | 2,804 | Upgrade |
Depreciation & Amortization | - | 557.8 | 510.48 | 501.28 | 500.08 | 487.08 | Upgrade |
Other Amortization | - | - | 3.99 | 1.96 | 0.41 | 11.76 | Upgrade |
Loss (Gain) From Sale of Assets | - | -0.3 | 1.83 | -1.11 | -0.17 | -32.67 | Upgrade |
Asset Writedown & Restructuring Costs | - | 12.3 | - | - | - | 30.42 | Upgrade |
Loss (Gain) From Sale of Investments | - | -2.7 | 2.92 | - | - | - | Upgrade |
Provision & Write-off of Bad Debts | - | 37.2 | 18.96 | 7.59 | 16.87 | 8.47 | Upgrade |
Other Operating Activities | - | 124.1 | 309.02 | 323.77 | 10.09 | 100.24 | Upgrade |
Change in Accounts Receivable | - | 343.5 | 1,611 | -944.22 | -1,939 | -654.19 | Upgrade |
Change in Inventory | - | 129.6 | 342.46 | 58.22 | -1,106 | -891.85 | Upgrade |
Change in Accounts Payable | - | -437.3 | -925.31 | -277.37 | 1,171 | -313.88 | Upgrade |
Operating Cash Flow | - | 2,446 | 3,589 | 1,333 | 704.14 | 1,550 | Upgrade |
Operating Cash Flow Growth | - | -31.86% | 169.22% | 89.34% | -54.56% | -38.20% | Upgrade |
Capital Expenditures | - | -1,772 | -2,263 | -1,648 | -1,520 | -882.31 | Upgrade |
Sale of Property, Plant & Equipment | - | 0.5 | 1.87 | 1.45 | 0.2 | 108.86 | Upgrade |
Investment in Securities | - | 2.7 | - | - | - | - | Upgrade |
Other Investing Activities | - | 122.1 | 24.97 | 7 | 23.15 | 55.66 | Upgrade |
Investing Cash Flow | - | -1,646 | -2,237 | -1,640 | -1,496 | -717.8 | Upgrade |
Short-Term Debt Issued | - | 409.2 | - | 13.97 | 2,028 | - | Upgrade |
Long-Term Debt Issued | - | 702.4 | 1,482 | 1,158 | - | - | Upgrade |
Total Debt Issued | - | 1,112 | 1,482 | 1,172 | 2,028 | - | Upgrade |
Short-Term Debt Repaid | - | - | -1,245 | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -776.1 | -459.36 | -558.61 | -68.69 | -349.67 | Upgrade |
Total Debt Repaid | - | -776.1 | -1,705 | -558.61 | -68.69 | -349.67 | Upgrade |
Net Debt Issued (Repaid) | - | 335.5 | -222.85 | 613.74 | 1,959 | -349.67 | Upgrade |
Issuance of Common Stock | - | - | - | 7.56 | - | - | Upgrade |
Repurchase of Common Stock | - | -731.7 | -598.5 | - | -738.38 | - | Upgrade |
Common Dividends Paid | - | -90.6 | -92.67 | -94.01 | -95.08 | -232.05 | Upgrade |
Other Financing Activities | - | -334.4 | -446.31 | -361.86 | -205.78 | -229.57 | Upgrade |
Financing Cash Flow | - | -821.2 | -1,360 | 165.42 | 920.25 | -811.29 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | - | -0 | - | Upgrade |
Net Cash Flow | - | -21.7 | -7.61 | -141.09 | 127.99 | 20.42 | Upgrade |
Free Cash Flow | - | 674.2 | 1,326 | -314.97 | -815.61 | 667.19 | Upgrade |
Free Cash Flow Growth | - | -49.15% | - | - | - | -67.09% | Upgrade |
Free Cash Flow Margin | - | 2.82% | 5.24% | -1.16% | -3.28% | 3.10% | Upgrade |
Free Cash Flow Per Share | - | 7.36 | 14.42 | -3.40 | -8.81 | 7.16 | Upgrade |
Cash Interest Paid | - | 334.4 | 313.08 | 361.86 | 205.79 | 229.57 | Upgrade |
Cash Income Tax Paid | - | 551.2 | 624 | 596.75 | 833.77 | 966.75 | Upgrade |
Levered Free Cash Flow | - | -145.45 | 1,028 | -802.36 | -1,169 | 150.05 | Upgrade |
Unlevered Free Cash Flow | - | 78.74 | 1,237 | -594.28 | -1,040 | 293.54 | Upgrade |
Change in Net Working Capital | - | 152.96 | -1,330 | 1,045 | 1,823 | 1,749 | Upgrade |
Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.